MTFB Motif Bio plc

10.01
+0.05  (+0%)
Previous Close 9.96
Open 9.6
Price To Book -43.51
Market Cap 148436918
Shares 14,833,012
Volume 1,127
Short Ratio
Av. Daily Volume 2,104

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

PDUFA date February 13, 2019.
Iclaprim - REVIVE-2
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 data released April 18, 2017 - primary endpoint of non-inferiority met.
Iclaprim -REVIVE-1
Acute bacterial skin and skin structure infections (ABSSSI)